A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung diseaseMasaki Hanibuchi, Yasuhiko Nishioka, Masahiko Azuma et al.|Lung Cancer|2018Cited by 31
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1Soji Kakiuchi, Yasuhiko Nishioka, Masaki Hanibuchi et al.|Respiratory Investigation|2016Cited by 27
Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in ratsKeiko Miyake, Saburo Sone, Kenji Tani et al.|The Journal of Medical Investigation|2012Cited by 18
Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of JapanTakanori Kanematsu, Saburo Sone, Masaki Hanibuchi et al.|The Journal of Medical Investigation|2010Cited by 15
Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University HospitalHirokazu Ogino, Yasuhiko Nishioka, Masaki Hanibuchi et al.|The Journal of Medical Investigation|2016Cited by 11